statistiche ricercatore

Continente	#
NA - Nord America	3.706
AS - Asia	501
EU - Europa	351
SA - Sud America	98
AF - Africa	12
Continente sconosciuto - Info sul continente non disponibili	3
OC - Oceania	2
Totale	4.673

Nazione	#
US - Stati Uniti d'America	3.678
SG - Singapore	159
CN - Cina	150
RU - Federazione Russa	117
IT - Italia	81
BR - Brasile	72
VN - Vietnam	49
FI - Finlandia	38
BD - Bangladesh	34
HK - Hong Kong	31
GB - Regno Unito	28
DE - Germania	23
CA - Canada	18
FR - Francia	16
IN - India	14
AE - Emirati Arabi Uniti	13
PL - Polonia	12
JP - Giappone	10
NL - Olanda	9
MX - Messico	8
CO - Colombia	7
IE - Irlanda	7
TR - Turchia	7
IQ - Iraq	6
ZA - Sudafrica	5
AR - Argentina	4
EC - Ecuador	4
ES - Italia	4
MY - Malesia	4
SA - Arabia Saudita	4
AT - Austria	3
BE - Belgio	3
CL - Cile	3
ID - Indonesia	3
IL - Israele	3
LT - Lituania	3
PY - Paraguay	3
EG - Egitto	2
ET - Etiopia	2
NZ - Nuova Zelanda	2
PK - Pakistan	2
SE - Svezia	2
TH - Thailandia	2
TW - Taiwan	2
VE - Venezuela	2
XK - ???statistics.table.value.countryCode.XK???	2
AZ - Azerbaigian	1
BO - Bolivia	1
CR - Costa Rica	1
DZ - Algeria	1
GA - Gabon	1
GE - Georgia	1
JM - Giamaica	1
JO - Giordania	1
KG - Kirghizistan	1
LB - Libano	1
MA - Marocco	1
NO - Norvegia	1
PE - Perù	1
PT - Portogallo	1
QA - Qatar	1
RS - Serbia	1
SI - Slovenia	1
SX - ???statistics.table.value.countryCode.SX???	1
SY - Repubblica araba siriana	1
UA - Ucraina	1
UY - Uruguay	1
UZ - Uzbekistan	1
Totale	4.673

Nome	#
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology	1.576
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology	1.359
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology	888
Echocardiographic Biventricular Coupling Index to Predict Precapillary Pulmonary Hypertension	240
Sex differences in the prognostic role of achieving target doses of heart failure medications: Data from the Swedish Heart Failure Registry	237
Diagnosis and management of patients with left ventricular hypertrophy: Role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association of the European Society of Cardiology	213
Contemporary medical therapy for heart failure across the ejection fraction spectrum: The OPTIPHARM-HF registry	67
Long-term outcomes following Sacubitril/Valsartan therapy for chronic HFrEF. Italian Real-World Multicenter Study	56
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry	48
Totale	4.684

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	6	0	0	0	0	0	0	0	0	0	4	1	1
2022/2023	23	1	2	2	1	3	1	0	5	1	0	7	0
2023/2024	55	1	2	8	2	3	4	3	0	1	1	16	14
2024/2025	3.442	1	1	14	3	19	18	40	72	33	1.564	1.212	465
2025/2026	1.158	70	146	106	106	97	83	139	54	123	86	73	75
Totale													4.684